Vývoj doporučení pro použití venofarmak v léčbě chronického žilního onemocnění - kde je jejich místo a kde jsou slabiny
[Development of recommendations for the use of venoactive drugs in the treatment of chronic venous disease - where they are effective and where they are not]
Jazyk čeština Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
36220421
PII: 131972
- Klíčová slova
- GRADE, Randomized controlled trials, level of evidence, pentoxifylline, strenght of recommendation, sulodexide, symptomatic treatment, venoactive drugs,
- MeSH
- chronická nemoc MeSH
- dolní končetina MeSH
- lidé MeSH
- mikrocirkulace MeSH
- varixy * diagnóza farmakoterapie MeSH
- žilní insuficience * farmakoterapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The article provides an overview of the development of recommendations for indications of venoactive drugs for treating symptoms and signs associated with chronic venous disease (CVD). Venoactive drugs may be beneficial in patients with subjective problems and/or swelling of the lower limbs, after surgery for varicose veins, in chronic venous insufficiency or in microcirculatory disorders. They are not indicated in asymptomatic patients with CVD, in the prevention of varicose veins or to prevent their progression. Drugs with proven efficacy in clinical trials should be preferred.
